Condition
MSI-H/dMMR Colorectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 MSI-H/dMMR Colorectal Cancer clinical trials that are recruiting, at sites in 16 countries (most in Australia (1), Austria (1), Belgium (1)). By phase: Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 16Countries
All recruiting trials (2)
-
Neoadjuvant and adjuvant AK104 for resectable MSI-H/dMMR colon cancer
This phase 3 trial will test whether giving the antibody AK104 before and after surgery works better than standard adjuvant chemotherapy for adults with resectable MSI‑H or dMMR colon cancer.
-
EIK1005 (Werner helicase inhibitor) alone or with pembrolizumab for advanced MSI-H/dMMR and other solid tumors
This trial tests whether EIK1005, given alone or together with pembrolizumab, can be safely given and help people with advanced solid tumors, especially MSI‑H/dMMR cancers.
Related topics
Quick answers
How many MSI-H/dMMR Colorectal Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in Australia (1 trial), Austria (1 trial), Belgium (1 trial), Finland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.